Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Fetal treatment and long-term neonatal outcomes in severe maternal red cell alloimmunization : a single-centre experience
Authors:ID Mesarič, Vita Andreja (Author)
ID Bricl, Irena (Author)
ID Hrastar, Erika (Author)
ID Kornhauser-Cerar, Lilijana (Author)
ID Lozar Krivec, Jana (Author)
ID Rus, Mihael (Author)
ID de Winter, Derek P (Author)
ID Premru-Sršen, Tanja (Author)
Files:.pdf PDF - Presentation file, download (310,25 KB)
MD5: A2B5AF1D138EA6E6931A998448202359
 
URL URL - Source URL, visit https://www.degruyterbrill.com/document/doi/10.1515/crpm-2024-0040/html
 
Language:English
Typology:1.03 - Other scientific articles
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Objectives: Haemolytic disease of the fetus and newborn (HDFN) occurs due to maternal IgG alloantibodies that actively cross the placenta and bind to paternally derived fetal antigens on the erythrocytes. The aims of this study were to describe the Slovenian cohort of patients with severe HDFN, who required fetal treatment, to review the fetal treatment strategies, and to describe pregnancy and neurodevelopmental outcomes. Case series presentation: Data on patients who developed severe HDFN between 2006 and 2021 and were treated at our institution were collected retrospectively. Primary care pediatricians were contacted regarding neurodevelopmental outcomes of surviving infants. There were 19 pregnancies affected with severe HDFN. The most commonly implicated antigen was RhD. Seventeen children were liveborn. Sixteen fetuses were treated with intrauterine transfusion (IUT). Two children had developmental delay at the corrected age of 2 years. Conclusions: In this study, the Slovenian national cohort of severe cases of HDFN is described for the first time. Prevalence of RhD alloimmunization was higher in comparison to the literature. A combined treatment with therapeutic plasmapheresis, immunoglobulins and IUT was successful. Three quarters of newborns were born in the late preterm period. Overall survival rate and long-term neonatal adverse outcomes in our cohort were in line with the literature.
Keywords:haemolytic disease of the fetus and the newborn, intrauterine transfusion, neurodevelopmental outcome, severe maternal alloimmunization
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. [1-8]
Numbering:Vol. 14, iss. 1, [Article no.] 20240040
PID:20.500.12556/DiRROS-29157 New window
UDC:618.2/.7
ISSN on article:2192-8932
DOI:10.1515/crpm-2024-0040 New window
COBISS.SI-ID:242160387 New window
Note:
Publication date in DiRROS:22.04.2026
Views:103
Downloads:62
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Case reports in perinatal medicine
Publisher:de Gruyter
ISSN:2192-8932
COBISS.SI-ID:522770713 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:hemolitična bolezen ploda in novorojenčka, intrauterina transfuzija, nevrorazvojni izid, huda aloimunizacija matere


Back